Sale disclosed
Orbimed Advisors +7 more
10% owner
Common Stock
- Reported value
- $191.45K
- Reported price
- $6.53 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Adicet Bio, Inc.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
10% owner
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
10% owner
Common Stock
10% owner
Common Stock
10% owner
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| +710% owner | Common StockSale2 trades | 31,719avg $6.52 / share | $206.77K | Apr 7Filed Apr 9 · 2d later | 2 filings
|
| +710% owner | Common StockSale2 trades | 72,939avg $6.42 / share | $468.08K | Apr 8Filed Apr 9 · 1d later | 2 filings
|
This reflects the filings imported so far, not a complete trading history.